carnitine has been researched along with Muscular Dystrophy, Duchenne in 7 studies
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A milder form of the disease, Becker muscular dystrophy (BMD), is characterised by the presence of a semi-functional truncated dystrophin, or the full-length dystrophin at reduced level." | 2.43 | [Pharmacological treatments for Duchenne and Becker dystrophies]. ( de la Porte, S; Voisin, V, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, H | 1 |
| Cai, X | 1 |
| Xu, K | 1 |
| Wu, Q | 1 |
| Xu, B | 1 |
| Lamhonwah, AM | 2 |
| Tein, I | 2 |
| Zolkipli, Z | 1 |
| Mai, L | 1 |
| Le Borgne, F | 1 |
| Guyot, S | 1 |
| Logerot, M | 1 |
| Beney, L | 1 |
| Gervais, P | 1 |
| Demarquoy, J | 1 |
| Sharma, U | 1 |
| Atri, S | 1 |
| Sharma, MC | 1 |
| Sarkar, C | 1 |
| Jagannathan, NR | 1 |
| Voisin, V | 1 |
| de la Porte, S | 1 |
| Hnia, K | 1 |
| Hugon, G | 1 |
| Rivier, F | 1 |
| Masmoudi, A | 1 |
| Mercier, J | 1 |
| Mornet, D | 1 |
1 review available for carnitine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
[Pharmacological treatments for Duchenne and Becker dystrophies].
Topics: Adrenal Cortex Hormones; Adult; Aminoglycosides; Animals; Carnitine; Child; Child, Preschool; Creati | 2005 |
6 other studies available for carnitine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis.
Topics: Amino Acids; Carnitine; Humans; Lipids; Male; Metabolomics; Muscular Dystrophy, Duchenne | 2023 |
Expression of the organic cation/carnitine transporter family (Octn1,-2 and-3) in mdx muscle and heart: Implications for early carnitine therapy in Duchenne muscular dystrophy to improve cellular carnitine homeostasis.
Topics: Animals; Carnitine; Diaphragm; Homeostasis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitoch | 2020 |
The mdx mouse as a model for carnitine deficiency in the pathogenesis of Duchenne muscular dystrophy.
Topics: Animals; Carnitine; Disease Models, Animal; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, | 2012 |
Exploration of lipid metabolism in relation with plasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitine.
Topics: Adolescent; Carnitine; Cell Membrane; Fatty Acids; Humans; Lipid Metabolism; Male; Mitochondria; Mus | 2012 |
Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study.
Topics: Adolescent; Adult; Carnitine; Child; Child, Preschool; Humans; Immunohistochemistry; In Vitro Techni | 2003 |
Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
Topics: Animals; Apoptosis; Calcium; Carnitine; Creatine Kinase; Diaphragm; Dystroglycans; Dystrophin; Free | 2007 |